Fresh off an infusion of funds from NexPhase Capital, Calcium has launched Vitamin MD, a medical education division. The new group will provide a range of disease state and brand-related educational services.
It will be headed up by EVP/medical director Lauren Lazar, MD, and VP/client engagement lead Brad Quosig, with support from Calcium president Greg Lewis and CEO Judy Capano.
“Medical education should be an integrated ecosystem that’s aligned with core brand strategic imperatives,” Lazar said in a statement. “Innovative educational approaches can serve the important needs of both providers and patients, while also delivering the measurable results clients are seeking.”
“Vitamin MD is well positioned to deliver the timely, responsible and progressive healthcare education the world profoundly needs,” Lewis added in the statement.
When the agency secured NexPhase Capital as an equity partner in November, Calcium founder and chairman Steven Michaelson predicted the type of expansion that Vitamin MD represents. “We can do what we’ve always done, which is invest in ourselves and our people, but on such a bigger level,” Michaelson said at the time.
According to the 2021 MM+M Agency 100, Calcium generated $35.9 million in revenue in 2020, up 71% from 2019. The company’s clients include Bristol Myers Squibb, Genentech and Acceleron Pharma.